Draft report on the development of a harmonised approach to exposure assessment methodologies for residues from veterinary medicinal products, feed additives and pesticides in food of animal origin

July 5, 2022

Tractor spraying a field of crops.

In 2020, the European Commission (EC) requested EMA and European Food Safety Authority (EFSA) for advice for the development of a harmonised approach on exposure assessment methodologies for residues from veterinary medicinal products (EMA), feed additives and pesticides in food of animal origin (EFSA). This work was undertaken under the EC mandate by a working group composed of CVMP experts, EFSA experts, specialists with expertise from the Joint FAO / WHO Expert Committee on Food Additives (JECFA) and the Joint Meeting on Pesticide Residues (JMPR), and an European Chemichal Agency (ECHA) observer. The draft report compares available models of consumer exposure and makes recommendation on a harmonised approach to be used by EMA and EFSA for the assessment of exposure to residues of veterinary medicines, feed additives and pesticides in food of animal origin.

Download the Draft Report

Interested in learning more? Contact us today to find out how we can help with your global regulatory needs

TAGS:

August 29, 2022

Meet the Expert: Lucy Radley

Our “Meet the Expert” series introduces you to our team of experts around the world. This “behind the curtain” view will help you get to know who we are on a professional and personal level, and...

Petri dish with bacteria growing.

June 21, 2022

Advice on the designation of antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans - in relation to implementing measures under Article 37(5) of Regulation

Regulatory and Procedural Guideline May 2022 EMA/CVMP/678496/2021-rev Introduction “According to Article 37(5) of Regulation (EU) 2019/6 (‘the Regulation’), the European Commission shall adopt...

Computer generated rendering molecules, cells, and DNA structures.

June 16, 2022

Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies

Guidance Document Draft Guidance for Industry June 2022 This guidance describes a standards recognition program for regenerative medicine therapies (SRP-RMT) at FDA’s Center for Biologics Evaluation...